 Our study suggests that dinosumab may be more effective than bisphosphonates, or placebos, in improving muscle strength and reducing fall risk in individuals with osteosarcopenia. This article was authored by Augusti Putisaka Ariyana, Sandra Suriarini, and C. D. C. Sciotti.